http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d77cc8edf67c075b9a854d1071a54ad
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Bornmann G. Bornmann |
| name | William G. Bornmann William G Bornmann |
| given-name | William G William G. William |
| organization-name | Authors' Affiliations: 1Department of Basic Pharmaceutical Sciences, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, West Virginia; Departments of 2Biochemistry, 3Pharmacology, and 4Oncology, Case Western Reserve University, Cleveland, Ohio; 5Department of Pharmacology, Laboratory of Molecular Cell Stress Responses, Program in Cell Stress and Cancer Nanomedicine, Simmons Cancer Center; 6Department of Surgery, UT Southwestern Medical Center at Dallas, Dallas; 7Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, Texas; 8Department of Radiation Oncology, University of Alabama-Birmingham, Birmingham, Alabama; and 9Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa 2Organic Synthesis Core Facility, 1Experimental Diagnostic Imaging and 6Experimental Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, Houston, Texas and Department of Experimental Diagnostic Imaging, University of Texas M. D. Anderson Cancer Center, Houston, TX 77054 3Experimental Diagnostic Imaging, and Department of Experimental Diagnostic Imaging, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030 Authors' Affiliations: 1Division of Hematology-Oncology, Department of Internal Medicine, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan and 2Graduate School of Biomedical Sciences, University of Texas Health Science Center; 3Department of Experimental Therapeutics, M.D. Anderson Cancer Center, Houston, Texas Authors' Affiliations: Departments of 1Pharmacology,2Radiation Oncology,3Biostatistics, and4Surgery, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center at Dallas, and5Department of Experimental Therapeutics, M. D. Anderson Cancer Center, Houston, Texas 4Experimental Therapeutics, and Organic Synthesis Core Facility, Sloan-Kettering Institute for Cancer Research, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 From the Division of Hematology/Oncology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, TX; the Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX; and the Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, NY. 9Department of Molecular Imaging, M.D. Anderson University, Houston, Texas 2Experimental Diagnostic Imaging, Authors' Affiliations: Departments of 1Thoracic and Cardiovascular Surgery and 2Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston; and 3Hamon Center for Therapeutic Oncology Research, The University of Texas Southwestern Medical Center; Dallas, Texas Organic Synthesis Core Facility, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, Department of Experimental Diagnostic Imaging, M.D. Anderson Cancer Center, Houston, Texas 77030, Laboratory of Tumor Vaccinology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, NMR Core Facility, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, and The Laboratory for Bioorganic Chemistry, Memorial... Organic Synthesis Core Facility, Sloan-Kettering Institute for Cancer Research, New York, New York 10021 Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, Texas. Department of Experimental Therapeutics, M. D. Anderson Cancer Center, University of Texas, Houston, TX Department of Pharmacology, Memorial Sloan–Kettering Cancer Center, New York, NY 10021; Authors' Affiliations: 1Departments of Pharmacology and 2Radiation Oncology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas; 3Departments of Pathology, Microbiology, and Immunology, University of South Carolina, Columbia, South Carolina; and 4Department of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Houston, Texas Departments of 1Surgical Oncology, 2Neurosurgery, 3Pediatrics and Child Neurology, 4Experimental Therapeutics, 5Systems Biology, 6Pathology, and 7Cancer Biology and 8Division of Quantitative Sciences, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 4Department of Experimental Diagnostic Imaging, University of Texas M. D. Anderson Cancer Center, Houston, Texas Department of Molecular, Cellular, and Developmental Biology, Yale University, 219 Prospect Street, New Haven, CT 06520-8103; and Preparative Synthesis Core Facility, Memorial Sloan–Kettering Cancer Center, 1275 York Avenue, New York, NY 10021 5Department of Experimental Therapeutics, MD Anderson Comprehensive Cancer Center, Houston, Texas. Authors' Affiliations: Department of 1Cancer Biology, 2Experimental Therapeutics, and 3GI Medical Oncology, UT MD Anderson Cancer Center, Houston, Texas Laboratories for Bioorganic Chemistry, Preclinical Pharmacology, and the Preparative Synthesis Core Facility, The Sloan−Kettering Institute for Cancer, Research, 1275 York Avenue, New York, New York 10021, and The Department of Chemistry, Columbia University, Havemeyer Hall, New York, New York 10027 Fisher Center for Research on Alzheimer's Disease, Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY 10021; and Department of Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, NY 10021 |
Incoming Links
Total number of triples: 104.